Neuroprotective effects of EpoL against oxidative stress induced by soluble oligomers of Aβ peptide
In conclusion, EpoL, a new variant of Epo without hematopoietic activity, is of potential interest for the treatment of diseases related to oxidative stress in the CNS such as Alzheimer disease.Graphical abstract
Source: Redox Biology - Category: Biology Source Type: research
More News: Alzheimer's | Biology | Brain | Calcium | Hormones | Men | Neurology | Study | Toxicology